Bristol Myers Squibb's therapy meets mid-stage trial goal
BMY•Mid-stage trial meets main goal
Bristol Myers Squibb said on Tuesday its experimental cell therapy met the main goal of a mid-stage trial.
Related News
Facilities management firm ABM Industries' Q3 adj EPS beats on lower costs
ABM•
KIDZ AI appoints Karan Bansal as AI security advisor
KIDZ•
IonQ Announces Increased Full-Year 2026 Financial Outlook Following Skywater Acquisition
IONQ•
Quantinuum secures USD 100 million CHIPS R&D award from US Commerce Department
GFS•
Philip Morris Outlook FY EPS USD 7.28-7.43
PM•